Skip to main content
PMC home page
Nucleic Acids Research logoLink to Nucleic Acids Research
. 1998 Sep 15;26(18):4160–4167. doi: 10.1093/nar/26.18.4160

RNA mimetics: oligoribonucleotide N3'-->P5' phosphoramidates.

S M Gryaznov 1, H Winter 1
PMCID: PMC147819  PMID: 9722635

Abstract

The synthesis and properties of novel RNA mimetics, oligoribonucleotide N3'-->P5' phosphoramidates, are described. These oligonucleotides contain 3'-aminoribonucleosides connected via N3'-->P5' phosphoramidate linkages, replacing the native RNA O3'-->P5' phosphodiester counterparts. The key monomers 2'-t-butyldimethylsilyl-3'-(monomethoxytrityl)-amino-5'-phospho ramidi tes were synthesized and used to prepare the oligonucleotide phosphoramidates using a solid phase methodology based on the phosphoramidite transfer reaction. Oligoribophosphoramidates are very resistant to enzymatic hydrolysis by snake venom phosphodiesterase. These compounds form stable duplexes with complementary natural phosphodiester DNA and RNA strands, as well as with 2'-deoxy N3'-->P5' phosphoramidates. The increase in melting temperature, Delta T m, was 5-14 degrees C relative to the 2'-deoxy phosphoramidates for decanucleotides. Also, the thermal stability of the ribophosphoramidatehomoduplex was noticeably higher (Delta T m +9.5 degrees C) than that for the isosequential 2'-deoxy phosphoramidate complex. Furthermore, the oligopyrimidine ribo N3'-->P5' phosphoramidate formed an extremely stable triplex with an oligopurine/oligopyrimidine DNA duplex with Delta T m +14.3 degrees C relative to the 2'-deoxy N3'-->P5' phosphoramidate counterpart. The properties of the oligoribonucleotide N3'-->P5' phosphoramidates indicate that these compounds can be used as hydrolytically stable structural and functional RNA mimetics.

Full Text

The Full Text of this article is available as a PDF (94.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bartel D. P., Szostak J. W. Isolation of new ribozymes from a large pool of random sequences [see comment]. Science. 1993 Sep 10;261(5127):1411–1418. doi: 10.1126/science.7690155. [DOI] [PubMed] [Google Scholar]
  2. Cech T. R. A model for the RNA-catalyzed replication of RNA. Proc Natl Acad Sci U S A. 1986 Jun;83(12):4360–4363. doi: 10.1073/pnas.83.12.4360. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Cech T. R., Zaug A. J., Grabowski P. J. In vitro splicing of the ribosomal RNA precursor of Tetrahymena: involvement of a guanosine nucleotide in the excision of the intervening sequence. Cell. 1981 Dec;27(3 Pt 2):487–496. doi: 10.1016/0092-8674(81)90390-1. [DOI] [PubMed] [Google Scholar]
  4. Chen J. K., Schultz R. G., Lloyd D. H., Gryaznov S. M. Synthesis of oligodeoxyribonucleotide N3'-->P5' phosphoramidates. Nucleic Acids Res. 1995 Jul 25;23(14):2661–2668. doi: 10.1093/nar/23.14.2661. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Chen J. K., Schultz R. G., Lloyd D. H., Gryaznov S. M. Synthesis of oligodeoxyribonucleotide N3'-->P5' phosphoramidates. Nucleic Acids Res. 1995 Jul 25;23(14):2661–2668. doi: 10.1093/nar/23.14.2661. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Christoffersen R. E., Marr J. J. Ribozymes as human therapeutic agents. J Med Chem. 1995 Jun 9;38(12):2023–2037. doi: 10.1021/jm00012a001. [DOI] [PubMed] [Google Scholar]
  7. Ding D., Grayaznov S. M., Lloyd D. H., Chandrasekaran S., Yao S., Ratmeyer L., Pan Y., Wilson W. D. An oligodeoxyribonucleotide N3'--> P5' phosphoramidate duplex forms an A-type helix in solution. Nucleic Acids Res. 1996 Jan 15;24(2):354–360. doi: 10.1093/nar/24.2.354. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Doudna J. A., Couture S., Szostak J. W. A multisubunit ribozyme that is a catalyst of and template for complementary strand RNA synthesis. Science. 1991 Mar 29;251(5001):1605–1608. doi: 10.1126/science.1707185. [DOI] [PubMed] [Google Scholar]
  9. Ellington A. D., Szostak J. W. In vitro selection of RNA molecules that bind specific ligands. Nature. 1990 Aug 30;346(6287):818–822. doi: 10.1038/346818a0. [DOI] [PubMed] [Google Scholar]
  10. Escudé C., Giovannangeli C., Sun J. S., Lloyd D. H., Chen J. K., Gryaznov S. M., Garestier T., Hélène C. Stable triple helices formed by oligonucleotide N3'-->P5' phosphoramidates inhibit transcription elongation. Proc Natl Acad Sci U S A. 1996 Apr 30;93(9):4365–4369. doi: 10.1073/pnas.93.9.4365. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Gold L. Oligonucleotides as research, diagnostic, and therapeutic agents. J Biol Chem. 1995 Jun 9;270(23):13581–13584. doi: 10.1074/jbc.270.23.13581. [DOI] [PubMed] [Google Scholar]
  12. Gryaznov S., Skorski T., Cucco C., Nieborowska-Skorska M., Chiu C. Y., Lloyd D., Chen J. K., Koziolkiewicz M., Calabretta B. Oligonucleotide N3'-->P5' phosphoramidates as antisense agents. Nucleic Acids Res. 1996 Apr 15;24(8):1508–1514. doi: 10.1093/nar/24.8.1508. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Guerrier-Takada C., Gardiner K., Marsh T., Pace N., Altman S. The RNA moiety of ribonuclease P is the catalytic subunit of the enzyme. Cell. 1983 Dec;35(3 Pt 2):849–857. doi: 10.1016/0092-8674(83)90117-4. [DOI] [PubMed] [Google Scholar]
  14. Herschlag D., Cech T. R. DNA cleavage catalysed by the ribozyme from Tetrahymena. Nature. 1990 Mar 29;344(6265):405–409. doi: 10.1038/344405a0. [DOI] [PubMed] [Google Scholar]
  15. Jellinek D., Green L. S., Bell C., Lynott C. K., Gill N., Vargeese C., Kirschenheuter G., McGee D. P., Abesinghe P., Pieken W. A. Potent 2'-amino-2'-deoxypyrimidine RNA inhibitors of basic fibroblast growth factor. Biochemistry. 1995 Sep 12;34(36):11363–11372. doi: 10.1021/bi00036a009. [DOI] [PubMed] [Google Scholar]
  16. Joyce G. F., Schwartz A. W., Miller S. L., Orgel L. E. The case for an ancestral genetic system involving simple analogues of the nucleotides. Proc Natl Acad Sci U S A. 1987 Jul;84(13):4398–4402. doi: 10.1073/pnas.84.13.4398. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Lisziewicz J., Sun D., Smythe J., Lusso P., Lori F., Louie A., Markham P., Rossi J., Reitz M., Gallo R. C. Inhibition of human immunodeficiency virus type 1 replication by regulated expression of a polymeric Tat activation response RNA decoy as a strategy for gene therapy in AIDS. Proc Natl Acad Sci U S A. 1993 Sep 1;90(17):8000–8004. doi: 10.1073/pnas.90.17.8000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Nelson Jeffrey S., Fearon Karen L., Nguyen Mark Q., McCurdy Sarah N., Frediani Jeff E., Foy Michael F., Hirschbein Bernard L. N3'-->P5' Oligodeoxyribonucleotide Phosphoramidates: A New Method of Synthesis Based on a Phosphoramidite Amine-Exchange Reaction. J Org Chem. 1997 Oct 17;62(21):7278–7287. doi: 10.1021/jo970801t. [DOI] [PubMed] [Google Scholar]
  19. Paolella G., Sproat B. S., Lamond A. I. Nuclease resistant ribozymes with high catalytic activity. EMBO J. 1992 May;11(5):1913–1919. doi: 10.1002/j.1460-2075.1992.tb05244.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Pieken W. A., Olsen D. B., Benseler F., Aurup H., Eckstein F. Kinetic characterization of ribonuclease-resistant 2'-modified hammerhead ribozymes. Science. 1991 Jul 19;253(5017):314–317. doi: 10.1126/science.1857967. [DOI] [PubMed] [Google Scholar]
  21. Rigl C. T., Lloyd D. H., Tsou D. S., Gryaznov S. M., Wilson W. D. Structural RNA mimetics: N3'-->P5' phosphoramidate DNA analogs of HIV-1 RRE and TAR RNA form A-type helices that bind specifically to Rev and Tat-related peptides. Biochemistry. 1997 Jan 21;36(3):650–659. doi: 10.1021/bi961980w. [DOI] [PubMed] [Google Scholar]
  22. Schultz R. G., Gryaznov S. M. Oligo-2'-fluoro-2'-deoxynucleotide N3'-->P5' phosphoramidates: synthesis and properties. Nucleic Acids Res. 1996 Aug 1;24(15):2966–2973. doi: 10.1093/nar/24.15.2966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Sullenger B. A., Gallardo H. F., Ungers G. E., Gilboa E. Overexpression of TAR sequences renders cells resistant to human immunodeficiency virus replication. Cell. 1990 Nov 2;63(3):601–608. doi: 10.1016/0092-8674(90)90455-n. [DOI] [PubMed] [Google Scholar]
  24. Tuerk C., Gold L. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science. 1990 Aug 3;249(4968):505–510. doi: 10.1126/science.2200121. [DOI] [PubMed] [Google Scholar]
  25. Zielinski W. S., Orgel L. E. Oligoaminonucleoside phosphoramidates. Oligomerization of dimers of 3'-amino-3'-deoxy-nucleotides (GC and CG) in aqueous solution. Nucleic Acids Res. 1987 Feb 25;15(4):1699–1715. doi: 10.1093/nar/15.4.1699. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Nucleic Acids Research are provided here courtesy of Oxford University Press

RESOURCES